Ansah-Addo Stephen, Alexis Andrew F
Mr. Ansah-Addo is with the Albert Einstein College of Medicine in the Bronx, New York, New York.
Dr. Alexis is with the Department of Dermatology at Mount Sinai St. Luke's and Mount Sinai West in New York, New York.
J Clin Aesthet Dermatol. 2021 Jan;14(1):21-23. Epub 2021 Jan 1.
Pretibial myxedema (PM) is a rare extrathyroid condition seen in about 0.5 to 4.3 percent of individuals with hyperthyroidism due to Graves' disease, often presenting with associated thyroid orbitopathy. In most cases, patients with PM have elevated levels of thyroid antibodies, such as thyroid peroxidase (TPO), thyroglobulin, and-most especially-thyroid-stimulating hormone receptor antibodies. We present a rare case of biopsy-proven PM in a euthyroid patient with no history of Graves' disease or Hashimoto's disease. TPO and thyroglobulin antibody counts were slightly elevated but less than what is typically seen in PM and thyroid-stimulating hormone receptor antibodies (thyrotrophin-binding inhibitor immunoglobulin) were negative.
胫前黏液性水肿(PM)是一种罕见的甲状腺外疾病,在约0.5%至4.3%的格雷夫斯病所致甲状腺功能亢进患者中可见,常伴有甲状腺眼眶病。在大多数情况下,PM患者的甲状腺抗体水平升高,如甲状腺过氧化物酶(TPO)、甲状腺球蛋白,尤其是促甲状腺激素受体抗体。我们报告一例经活检证实的PM罕见病例,该患者甲状腺功能正常,无格雷夫斯病或桥本氏病病史。TPO和甲状腺球蛋白抗体计数略有升高,但低于PM患者的典型水平,促甲状腺激素受体抗体(促甲状腺素结合抑制免疫球蛋白)为阴性。